Tasaka K, Akagi M, Mio M, Miyoshi K, Nakaya N
Int Arch Allergy Appl Immunol. 1987;83(4):348-53. doi: 10.1159/000234367.
Oxatomide at concentrations of 0.01-10 microM inhibited not only an increase in 45Ca uptake but also the intracellular Ca2+ release induced by compound 48/80 in rat peritoneal mast cells. At higher concentrations, ketotifen or other calcium antagonists caused similar inhibitory effects. However, the inhibitory effect of oxatomide on the 45Ca uptake into rat neonatal heart cells was much weaker than that of verapamil. Through image processing of quin 2-stained mast cells, it was revealed that oxatomide inhibited Ca2+ release from the intracellular store. Although oxatomide alone did not affect cAMP and cGMP contents in sensitized guinea pig lung samples, the drug effectively prevented changes in the nucleotide contents evoked by antigen challenge. These results suggest that the inhibitory effect of oxatomide on histamine release may be caused by a combination of prevention of Ca uptake, which is highly selective toward mast cells; inhibition of Ca2+ release from the intracellular Ca store, and elevation of the cAMP content in mast cells.
0.01 - 10微摩尔浓度的奥沙米特不仅抑制了45Ca摄取的增加,还抑制了化合物48/80诱导的大鼠腹膜肥大细胞内Ca2+释放。在较高浓度下,酮替芬或其他钙拮抗剂也产生了类似的抑制作用。然而,奥沙米特对大鼠新生心脏细胞45Ca摄取的抑制作用远弱于维拉帕米。通过对喹吖因2染色的肥大细胞进行图像处理发现,奥沙米特抑制了细胞内储存库的Ca2+释放。虽然单独使用奥沙米特不影响致敏豚鼠肺组织样本中的cAMP和cGMP含量,但该药物有效地阻止了抗原攻击引起的核苷酸含量变化。这些结果表明,奥沙米特对组胺释放的抑制作用可能是由以下因素共同作用引起的:对肥大细胞具有高度选择性的Ca摄取的预防;细胞内Ca储存库中Ca2+释放的抑制;以及肥大细胞中cAMP含量的升高。